John O. Trent

Molecular modeling of drug-DNA interactions: Facts and fantasies

Stephen Neidle, John O. Trent, S. Neidle, 1996 .

Keto acid phosphoranes: structure, synthesis, and bromolactonisation

John O. Trent, 1992 .

A simple, Automated Quasi‐4D‐QSAR, Quasi‐multi Way PLS Approach to Develop Highly Predictive QSAR Models for Highly Flexible CXCR4 Inhibitor Cyclic Pentapeptide Ligands Using Scripted Common Molecular Modeling Tools

Zixuan Wang, Stephen C. Peiper, Nobutaka Fujii, 2005 .

Molecular Docking of Intercalators and Groove-Binders to Nucleic Acids Using Autodock and Surflex

Jonathan B. Chaires, John O. Trent, Patrick A. Holt, 2008, J. Chem. Inf. Model..

Structure-Based Drug Discovery: Computational Virtual Screening

Jonathan B. Chaires, John O. Trent, William L. Dean, 2017 .

Discovery of novel triple helical DNA intercalators by an integrated virtual and actual screening platform

Jonathan B. Chaires, Lucjan Strekowski, John O. Trent, 2009, Nucleic acids research.

Mutations in growth factor independent-1 associated with human neutropenia block murine granulopoiesis through colony stimulating factor-1.

John O. Trent, H. Leighton Grimes, S. Bertolone, 2008, Immunity.

β-Arrestin-dependent Constitutive Internalization of the Human Chemokine Decoy Receptor D6*

Alberto Mantovani, John O. Trent, Robert J. Lefkowitz, 2004, Journal of Biological Chemistry.